Table 1:
Characteristics of the study and reference cases
| Study Cases (n=109) | Reference Cases AML post induction chemotherapy (n=56) | P value in comparison with the study group | |
|---|---|---|---|
| Patient gender (M:F) | 62:47 | 34:22 | Non-significant |
| Patient age at therapy, years, median (range) | 49 (4–75) | 60 (19–75) | 0.0004 |
| CD56 positive cell density, cells/HPF, median (range) | 3.4 (0.1–95.8)1 | 8.2 (0.7–17.25)3 | 0.001 |
| Low power CD56 percentage, median (range) | 1.8 (0–42.5)1 | 0 (0 – 3)3 | <0.0001 |
| NK cells as a percentage of lymphocytes by flow cytometry, median (range) | 19.8 (0–99.6)2 | 5.5 (1 – 38)4 | Non-significant |
1
n=89;
2
n=54;
3
n=50;
4
n=46